English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Sinovac Announces Success for Phase I Trial of EV71 Vaccine

May. 24, 2011

Sinovac Biotech reported positive results from a Phase I trial of its vaccine for human enterovirus 71 (EV71), the virus that causes Hand, Foot, and Mouth Disease (HFMD). The trial was approved by SFDA and started last December with 168 subjects including adults, children and infants. The phase II trial will be conducted within 1-2 months.